A NOVEL DES FOR DIABETIC PATIENTS IN CAD TREATMENT

• Research type

  Research Study

• Full title

  DEDICATE Registry (DRUG ELUTING STENT FOR DIABETIC PATIENTS IN CORONARY ARTERY DISEASE TREATMENT): A post market registry of ABLUMINUS® Sirolimus eluting coronary stent system for percutaneous intervention in patients with diabetes mellitus

• IRAS ID

  243631

• Contact name

  Ian Menown

• Contact email

  ian.menown@southerntrust.hscni.net

• Sponsor organisation

  Southern HSC Trust

• Duration of Study in the UK

  7 years, 0 months, 1 days

• Research summary

  The DEDICATE registry aims to assess clinical outcomes of 1000 patients from several European sites who have already undergone percutaneous coronary intervention (PCI) according to routine standard practice with the CE marked Abluminus stent. The registry will involve telephone contact to obtain clinical outcome information at 1 month, 6 months 12 months, and then yearly up to 5 years.

• REC name

  London - Queen Square Research Ethics Committee

• REC reference

  18/LO/0823

• Date of REC Opinion

  24 May 2018

• REC opinion

  Further Information Favourable Opinion